Sundrug Co (TSE:9989) Cyclically Adjusted Revenue per Share: 円6,215.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9989 Sundrug Co Ltd TSE:9989
75 GF Score
Price 円3,776.00
GF Value 円4,748.70
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Sundrug Co Cyclically Adjusted Revenue per Share?

Sundrug Co TSE:9989 +0.03% 75 Cyclically Adjusted Revenue per Share is 円6,215.41 as of Mar. 2026. GuruFocus rates TSE:9989 with a GF Score™ of 75/100 and a GF Value™ of 円4,748.70 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sundrug Co's adjusted revenue per share for the three months ended in Mar. 2026 was 円1,767.897. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円6,215.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sundrug Co's average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sundrug Co was 8.30% per year. The lowest was 6.00% per year. And the median was 7.05% per year.

As of today (2026-07-25), Sundrug Co's current stock price is 円3776.00. Sundrug Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円6,215.41. Sundrug Co's Cyclically Adjusted PS Ratio of today is 0.61.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sundrug Co was 1.54. The lowest was 0.58. And the median was 0.80.


Sundrug Co  (TSE:9989) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sundrug Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3776.00/6215.41
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sundrug Co was 1.54. The lowest was 0.58. And the median was 0.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sundrug Co Cyclically Adjusted Revenue per Share Related Terms


Sundrug Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sundrug Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sundrug Co Cyclically Adjusted Revenue per Share Chart

Sundrug Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,634.97 5,024.76 5,407.98 5,886.31 6,215.41

Sundrug Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,886.31 5,981.44 6,059.59 6,173.84 6,215.41

Sundrug Co Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Sundrug Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sundrug Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sundrug Co's Cyclically Adjusted PS Ratio falls into.


TSE:9989
75GF Score
Sundrug Co Ltd TSE:9989
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sundrug Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sundrug Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1767.897/112.7000*112.7000
=1,767.897

Current CPI (Mar. 2026) = 112.7000.

Sundrug Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1,072.646 98.100 1,232.285
201609 1,111.286 98.000 1,277.979
201612 1,186.498 98.400 1,358.926
201703 1,103.424 98.100 1,267.644
201706 1,177.979 98.500 1,347.799
201709 1,203.496 98.800 1,372.814
201712 1,260.452 99.400 1,429.104
201803 1,182.384 99.200 1,343.293
201806 1,245.014 99.200 1,414.446
201809 1,259.242 99.900 1,420.586
201812 1,301.826 99.700 1,471.573
201903 1,224.930 99.700 1,384.650
201906 1,303.848 99.800 1,472.381
201909 1,406.335 100.100 1,583.356
201912 1,262.250 100.500 1,415.478
202003 1,312.156 100.300 1,474.377
202006 1,341.292 99.900 1,513.149
202009 1,365.432 99.900 1,540.382
202012 1,405.325 99.300 1,594.966
202103 1,312.744 99.900 1,480.943
202106 1,404.594 99.500 1,590.932
202109 1,390.196 100.100 1,565.186
202112 1,410.336 100.100 1,587.861
202203 1,343.268 101.100 1,497.392
202206 1,423.507 101.800 1,575.926
202209 1,477.622 103.100 1,615.209
202212 1,542.152 104.100 1,669.554
202303 1,461.648 104.400 1,577.852
202306 1,557.749 105.200 1,668.805
202309 1,620.844 106.200 1,720.048
202312 1,661.066 106.800 1,752.829
202403 1,588.729 107.200 1,670.240
202406 1,663.546 108.200 1,732.732
202409 1,718.737 108.900 1,778.711
202412 1,778.508 110.700 1,810.640
202503 1,694.698 111.100 1,719.104
202506 1,775.789 111.700 1,791.687
202509 1,801.588 112.000 1,812.848
202512 1,857.437 113.000 1,852.506
202603 1,767.897 112.700 1,767.897

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円6,215.41 mean?
Sundrug Co (TSE:9989) has a Cyclically Adjusted Revenue per Share of 円6,215.41 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sundrug Co and its competitors.
Is Sundrug Co's Cyclically Adjusted Revenue per Share too high?
Sundrug Co's current Cyclically Adjusted Revenue per Share is 円6,215.41. Overall, Sundrug Co has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Cyclically Adjusted Revenue per Share compare to competitors?
Sundrug Co's Cyclically Adjusted Revenue per Share of 円6,215.41 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sundrug Co and its competitors. Sundrug Co's current Cyclically Adjusted Revenue per Share is 円6,215.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Based on GuruFocus' analysis, Sundrug Co (TSE:9989) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,748.70, compared to a current price of 円3,776.00 — trading 20.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円6,215.41. Sundrug Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sundrug Co (TSE:9989), the current Cyclically Adjusted Revenue per Share is 円6,215.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sundrug Co (TSE:9989) Overvalued in 2026?

Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued. The current stock price of 円3,776.00 is trading 20.5% below its estimated GF Value™ of 円4,748.70. GuruFocus considers Sundrug Co to be Modestly Undervalued.

Key valuation signals for TSE:9989:

  • Cyclically Adjusted Revenue per Share: 円6,215.41
  • GF Value™: 円4,748.70 vs. price of 円3,776.00 (20.5% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the TSE:9989 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sundrug Co Business Description

Address 1-38-1 Wakamatsucho, Fuchu-shi, Tokyo, JPN, 183-0005
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
75GF Score

Get the complete analysis for TSE:9989

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,776.00
Price
円4,748.70
GF Value